VTRS Stock Overview
Operates as a healthcare company worldwide. More details
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 3/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 2/6 |
Viatris Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$12.82 |
| 52 Week High | US$12.82 |
| 52 Week Low | US$8.32 |
| Beta | 0.93 |
| 11 Month Change | 19.70% |
| 3 Month Change | 22.68% |
| 1 Year Change | 48.59% |
| 33 Year Change | 13.51% |
| 5 Year Change | n/a |
| Change since IPO | -7.77% |
Recent News & Updates
Recent updates
Shareholder Returns
| VTRS | AT Pharmaceuticals | AT Market | |
|---|---|---|---|
| 7D | 6.8% | 3.0% | -0.3% |
| 1Y | 48.6% | 5.7% | 2.5% |
Return vs Industry: VTRS exceeded the Austrian Pharmaceuticals industry which returned 3.2% over the past year.
Return vs Market: VTRS exceeded the Austrian Market which returned 2.3% over the past year.
Price Volatility
| VTRS volatility | |
|---|---|
| VTRS Average Weekly Movement | 4.3% |
| Pharmaceuticals Industry Average Movement | 5.3% |
| Market Average Movement | 3.7% |
| 10% most volatile stocks in AT Market | 6.5% |
| 10% least volatile stocks in AT Market | 1.8% |
Stable Share Price: VTRS has not had significant price volatility in the past 3 months compared to the Austrian market.
Volatility Over Time: VTRS's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1961 | 32,000 | Scott Smith | www.viatris.com |
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs).
Viatris Inc. Fundamentals Summary
| VTRS fundamental statistics | |
|---|---|
| Market cap | €15.19b |
| Earnings (TTM) | -€848.23m |
| Revenue (TTM) | €14.45b |
1.1x
P/S Ratio-18.1x
P/E RatioIs VTRS overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| VTRS income statement (TTM) | |
|---|---|
| Revenue | US$15.05b |
| Cost of Revenue | US$8.72b |
| Gross Profit | US$6.32b |
| Other Expenses | US$7.21b |
| Earnings | -US$883.30m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.74 |
| Gross Margin | 42.03% |
| Net Profit Margin | -5.87% |
| Debt/Equity Ratio | 79.5% |
How did VTRS perform over the long term?
See historical performance and comparisonDividends
3.6%
Current Dividend Yield-65%
Payout RatioDoes VTRS pay a reliable dividends?
See VTRS dividend history and benchmarks| Viatris dividend dates | |
|---|---|
| Ex Dividend Date | Nov 22 2024 |
| Dividend Pay Date | Dec 13 2024 |
| Days until Ex dividend | 2 days |
| Days until Dividend pay date | 19 days |
Does VTRS pay a reliable dividends?
See VTRS dividend history and benchmarks